Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Proponents often stress the opportunity for substantial therapeutic outcomes, particularly in diseases where conventional treatments have proven inadequate. However, crucially important to consider the substantial financial investment associated with